November 28, 2023

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist

Listen Later

28 minutes

Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)?

Credit available for this activity expires: 11/21/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998529?ecd=bdc_podcast_libsyn_mscpedu

...more

View all episodes

View all episodes

Download on the App Store

Download on the App Store

Get it on Google Play

Keeping Current CME

By Medscape

4.3

2323 ratings

November 28, 2023

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist

Listen Later

28 minutes

Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)?

Credit available for this activity expires: 11/21/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998529?ecd=bdc_podcast_libsyn_mscpedu

...more